Fluid Responsiveness Evaluation by a Non-invasive Method in CHildren
FRENCH
1 other identifier
observational
21
1 country
1
Brief Summary
In this study, the investigators aim to validate a non-invasive marker of fluid-responsiveness in children with acute circulatory failure based on standardized abdominal compression. This would allow physicians to identify which patient could benefit from a fluid expansion, thus avoiding a potentially useless or even dangerous fluid expansion, leading to fluid overload. To this end, the investigators will evaluate the diagnostic accuracy (sensitivity and specificity) of stroke volume variation induced by standardized abdominal compression for the diagnosis of fluid responsiveness (based on the gold-standard test: significant increase in cardiac index after fluid expansion).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 2, 2023
CompletedFirst Posted
Study publicly available on registry
June 26, 2023
CompletedJune 26, 2023
June 1, 2023
12 months
June 2, 2023
June 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of the index test (ΔSVi-AC) for the diagnosis of fluid responsiveness
Diagnostic accuracy of the index test (ΔSVi-AC) for the diagnosis of fluid responsiveness, defined by an increase of cardiac output \> 15% after fluid expansion (ΔCO-FE \> 15%, gold-standard test) Index test (ΔSVi-AC) will be calculated as the difference between Stroke Volume (SV) after abdominal compression and SV at baseline, divided by SV at baseline (%). SV will be measured by echocardiographic assessment. Gold-standard test (ΔCO-FE) will be calculated as the difference between CO after fluid expansion and CO at baseline, divided by CO at baseline (%). CO will be measured by echocardiographic assessment.
after abdominal compression, 30 minutes to 4 hours after baseline
Secondary Outcomes (12)
Association between elevated ΔSVi-AC and capillary filling time (sec) -Baseline
at baseline (before fluid expansion)
Association between elevated ΔSVi-AC and capillary filling time (sec) -after abdominal compression
after abdominal compression, 30 minutes to 4 hours after baseline
Association between elevated ΔSVi-AC and Heart rate (bpm). -Baseline
at baseline (before fluid expansion)
Association between elevated ΔSVi-AC and Heart rate (bpm). -after abdominal compression
after abdominal compression, 30 minutes to 4 hours after baseline
Association between elevated ΔSVi-AC and Mean blood pressure (mmHg). -Baseline
at baseline (before fluid expansion)
- +7 more secondary outcomes
Study Arms (1)
study of diagnostic accuracy
Patients included in this study would have received fluid expansion in all cases, as the prescription of 10 to 20ml/kg crystalloid fluid expansion by the physician in charge is the main inclusion criterion.
Interventions
Fluid expansion will be delayed while our index test is performed. After fluid expansion, patient will undergo an echocardiographic assessment of response to fluid expansion (gold-standard). Our index test is the ΔSVi-AC: indexed percentage of stroke volume variation between baseline and during a standardized abdominal compression. Stroke volume will be assessed by transthoracic echocardiography. Patient will undergo 3 echocardiographic assessment: At baseline, During abdominal compression, After the 10 to 20ml/kg crystalloid fluid expansion Abdominal compression : a sphygmomanometer will be inflated to a pressure of less than 10 mmHg and will be applied to the center of the patient's abdomen. Then, a gentle compression on the sphygmomanometer will be performed, calibrated at 22 - 26 mmHg according to the sphygmomanometer. The echocardiographic assessments will take place between 10 and 60 seconds after the start of the compression, which will therefore last less than a minute.
Eligibility Criteria
At least 24 fluid expansion are needed, in 10 to 24 patients (maximum of 3 fluid expansion per patient). The "number needed to treat" was calculated with Obuchowski method, with an aphla risk of 0.05, a statistical power of 80%, a ratio "responder/nonresponder" of 1:1, and a predicted area under the receiver operating characteristic curve of 0.78 (based on previous studies). In order to be clinically relevant, since a large majority of patients admitted to our PICU are under 2 years of age, the investigators plan to include 24 fluid expansions administrated to patients under 2 years old. Therefore, the investigators might include more than 24 fluid expansions if some are administrated to patients older than 2 years old. Without this correction, our study might be underpowered if age is found to be a bias in fluid responsiveness.
You may qualify if:
- Age lower than 15 years old
- Prescription of a 10 to 20ml/kg crystalloid fluid expansion by the physician in charge
- Acute circulatory failure defined by the association of an A criteria (increase of heart rate more than two standard deviation for the age, decrease of systolic or mean blood pressure more than two standard deviation for ) and a B criteria (lactate more than 2 mmol/L, oliguria less than 1mL/kg/h, a capillary filling time more than 3 seconds, mottling)
- Patient hospitalized in PICU
You may not qualify if:
- Prematurity (term below 37 gestational week).
- Acute cardiogenic pulmonary edema
- Hemodynamic instability making the delay necessary for abdominal compression and ultrasonography dangerous for the patient
- Non corrected congenital cardiopathy, or inferior to 15 days postoperative.
- Intra-abdominal hypertension or painful abdominal palpation
- Abdominal surgery in the last 15 days
- Supine position contraindicated or deleterious
- No investigator available to assess ultrasonographic measures
- Impairment of echocardiographic acoustic window or restless patient making ultrasonography impossible
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bordeaux Hospital University
Bordeaux, 33076, France
Related Publications (1)
Gotchac J, Navion A, Belaroussi Y, Klifa R, Amedro P, Guichoux J, Brissaud O. Clinical value of calibrated abdominal compression plus transthoracic echocardiography to predict fluid responsiveness in critically ill infants: a diagnostic accuracy study. BMC Pediatr. 2025 May 7;25(1):361. doi: 10.1186/s12887-025-05728-z.
PMID: 40329198DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julien GOTCHAC, MD
Bordeaux hospital University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2023
First Posted
June 26, 2023
Study Start
February 3, 2022
Primary Completion
February 1, 2023
Study Completion
February 1, 2023
Last Updated
June 26, 2023
Record last verified: 2023-06